University of Ioannina
Σχεδιασμός και ανάπτυξη βιοαντιδραστηρίων κατάλληλων για την παραγωγή ή προσομοίωση δράσεων αντιοφικού ορού
Abstract
dc:descriptionVenomous snakes constitute a major global public health concern, particularly in regions with a high incidence of snakebite envenoming and limited access to specialized medical care. Envenomation by members of the family Viperidae can induce severe local and systemic effects, including hemorrhage, tissue necrosis, neurotoxicity, myotoxicity, and hemostatic disturbances, often resulting in permanent disability or death. The primary therapeutic approach remains the administration of antivenoms, which are traditionally produced by immunizing large mammals with whole venom. However, conventional antivenoms present significant limitations, including high production costs, limited availability, and the risk of severe adverse reactions. Phospholipases A₂ (PLA₂s) represent one of the most important toxin families in viper venoms, as they are involved in multiple pathological mechanisms, including neurotoxicity, myotoxicity, cytotoxicity, and inflammatory responses. Their high biological relevance, combined with the presence of conserved regions among different viper species, makes them attractive molecular targets for the development of broad-spectrum, toxin-specific antibodies. Within this context, the aim of the present doctoral dissertation was the rational design, synthesis, and immunological evaluation of synthetic peptide epitopes derived from viper venom phospholipases A₂, with the objective of generating toxin-specific antibodies and exploring their future application either in the development of next generation antivenoms or in toxin-removal technologies for the extracorporeal treatment of envenomed patients. Initially, homology studies were conducted among PLA₂s from various viper species, followed by detailed comparisons between Vipera ammodytes ammodytes and Vipera berus berus PLA₂s, as well as with human PLA₂ homologues. The results revealed a high degree of sequence homology among viper PLA₂s (>60–70%) and low similarity to the corresponding human proteins (<35%), supporting the feasibility of selective immunological targeting with minimal risk of cross-reactivity against human PLA₂s. Subsequently, computational analyses of antigenicity, hydrophilicity, surface accessibility, flexibility, mobility, and secondary structure were performed to identify suitable linear B-cell epitopes. Based on these analyses, two peptide epitopes were selected for synthesis: D128FLCKKESEK137 from Ammodytoxin A of Vipera ammodytes and S128SNCQENSDK137 from the PLA₂ of Vipera berus. The peptides were synthesized by solid-phase peptide synthesis (SPPS), purified by RP-HPLC, and characterized by mass spectrometry and NMR spectroscopy. The results confirmed the successful synthesis and high purity of both peptides, while NMR analysis indicated that they do not adopt a stable three-dimensional conformation in solution. To enhance immunogenicity, the peptides were conjugated to the synthetic peptide carrier CPSOC(3,9-Acm), which was appropriately modified to allow controlled attachment of the epitopes through a chemoselective thioether bond. This strategy led to the successful synthesis of the immunogenic constructs CPSOC(3,9-Acm;6,12-DFLC(Acm)KKESEK) and CPSOC(3,9-Acm;6,12-SSNC(Acm)QENSDK). These conjugates were subsequently used for chicken immunization, both individually and as a mixture, for the production of IgY antibodies. Chickens were selected for IgY antibody production due to the well-established advantages of IgY technology, including non-invasive antibody collection from egg yolks, high productivity, and a reduced likelihood of false-positive results in immunochemical assays. Antibodies were isolated using the polyethylene glycol 6000 (PEG 6000) precipitation protocol, followed by purification through dialysis and affinity chromatography using Sepharose-based columns coupled with the synthetic epitopes. ELISA assays demonstrated the successful production of specific antibodies with satisfactory titers. Significantly higher antibody titers were obtained following immunization with the mixture of the two immunogens compared with single-immunogen immunization. Furthermore, immunized chickens continued to produce specific antibodies with satisfactory activity for up to eight months after the final immunization. Regarding storage stability, the lyophilized antibody preparations exhibited substantially greater stability than antibodies stored in solution. A particularly important finding was the ability of the generated antibodies to recognize not only the synthetic immunogens but also whole native viper venoms. Specifically, antibodies raised against both the individual immunogens and the immunogen mixture successfully recognized Vipera ammodytes venom. Moreover, antibodies generated against the immunogen mixture exhibited cross-reactivity with venoms from Montivipera xanthina and Macrovipera schweizeri, confirming both the accessibility and the high conservation of the selected epitopes within the corresponding phospholipases A₂. In conclusion, this dissertation demonstrates that the rational design of synthetic phospholipase A₂ peptide epitopes and their corresponding immunogenic constructs can lead to the generation of specific and functional antibodies capable of recognizing both homologous and heterologous viper venoms. Consequently, this strategy may provide the foundation for the development of next-generation antivenom-related tools characterized by lower production costs, higher specificity, and broader accessibility.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Moulasioti, Vasiliki
- Μουλασιώτη, Βασιλική
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62476